The BIOSS Lim C pharmacoactive Stent has characteristics of design that makes it very suitable for the treatment of bifurcational lesions . The objective of the study is providing deeper knowledge into the results of this stent in the treatment of bifurcational lesions.

The BIOSS Lim C pharmacoactive Stent has characteristics of design that makes it very suitable for the treatment of bifurcational lesions . The objective of the study is providing deeper knowledge into the results of this stent in the treatment of bifurcational lesions.

Inclusion Criteria:

• Age over 18 years.
• Clinical indication of coronary angioplasty in bifurcated lesion.
• Bifurcated lesions with both distal branches at least 2 mm in diameter.
• The lesion must be located in the main branch, with a severe stenosis by visual estimation at some point in the main branch, with or without involvement of the lateral branch.
• Express acceptance and signature of informed consent.

Exclusion Criteria:

• Express rejection of the patient to participate in the study.
• Exclusive involvement of the lateral branch (Medina lesion 001).
• Contraindication for antiplatelet treatment.
• Lesions due to restenosis.
• Lesions in saphenous grafts.
• Total chronic occlusions.
• Cardiogenic shock.

Patients with ischemic heart disease referred for coronary revascularization will be included with susceptible lesion of coronary intervention in bifurcation.